A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)

NCT02754830 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: LY3303560 - IV
DRUG: Saline Solution - IV
DRUG: LY3303560 - SC

Sponsor

Eli Lilly and Company